Top Markets
#1 Purr Purr +57.78%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +34.50%
#4 Kinetiq Kinetiq +25.62%
#5 ApeX ApeX +23.09%
#6 Non-Playable Coin Non-Playable Coin +20.44%
#7 OriginTrail OriginTrail +19.45%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.44%
#9 龙虾 (Lobster) 龙虾 (Lobster) +18.17%
#10 Zora Zora +18.01%
Coin of the day
Purr Purr
Настройки
Язык
Pусский
Валюта
USD
Тема
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Ранг среди акций #21276
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Цена акции
$10.04
Последняя синхронизация: 2026-08-21
Рыночная капитализация
$111.12M
Изменение (1 день)
-1.43%
Изменение (1 год)
-40.73%
Страна
KR
Торговля Onconic Therapeutics (476060)

Категория

Healthcare
Коэффициент P/B для Onconic Therapeutics (476060)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Onconic Therapeutics, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Onconic Therapeutics с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH